CSIMarket
 


Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Capital Expenditures Growth by Quarter and Year

Boston Scientific's Capital Expenditures results by quarter and year




BSX Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 159.00 186.00 76.00
III Quarter September - 49.00 121.00 74.00
II Quarter June - 68.00 -162.00 60.00
I Quarter March 75.00 100.00 106.00 79.00
FY   75.00 376.00 251.00 289.00



BSX Capital Expenditures first quarter 2021 Y/Y Growth Comment
Boston Scientific Corporation reported fall in Capital Expenditures in the first quarter by -25% to $ 75.00 millions, from the same quarter in 2020.
The drop in the first quarter Boston Scientific Corporation's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures increase of 10.35%.

Looking into first quarter results within Medical Equipment & Supplies industry 50 other companies have achieved higher Capital Expenditures growth. While Boston Scientific Corporation' s Capital Expenditures drop of -25% ranks overall at the positon no. 1514 in the first quarter.




BSX Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -14.52 % 144.74 % 26.67 %
III Quarter September - -59.5 % 63.51 % 8.82 %
II Quarter June - - - -46.43 %
I Quarter March -25 % -5.66 % 34.18 % -66.81 %
FY   - 49.8 % -13.15 % -39.54 %

Financial Statements
Boston Scientific's first quarter 2021 Capital Expenditures $ 75.00 millions BSX's Income Statement
Boston Scientific's first quarter 2020 Capital Expenditures $ 100.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Capital Expenditures Growth >>


BSX Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 224.49 % 53.72 % 2.7 %
III Quarter September - -27.94 % - 23.33 %
II Quarter June - -32 % - -24.05 %
I Quarter March -52.83 % -46.24 % 39.47 % 31.67 %
FY (Year on Year)   - 49.8 % -13.15 % -39.54 %




Capital Expenditures first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #226
Overall #1514

Capital Expenditures Y/Y Growth Statistics
High Average Low
224.49 % 10.35 % -78.29 %
(Dec 31 2020)   (March 31, 2012)
Capital Expenditures first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #226
Overall #1514
Capital Expenditures Y/Y Growth Statistics
High Average Low
224.49 % 10.35 % -78.29 %
(Dec 31 2020)   (March 31, 2012)

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Boston Scientific's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
224.49 % 10.35 % -78.29 %
(Dec 31 2020)  


BSX's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2021 Boston Scientific Corporation realized fall in Capital Expenditures sequentially by -52.83% to $ 75.00 millions, from $ 159.00 millions declared in the previous quarter.

If you look into recent shortcoming in the quarter, you must take into consideration, that frequently I. Quarter performance occur softer in contrast to the forth quarter

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Boston Scientific's Capital Expenditures growth quarter on quarter, overall rank is 1514.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #226
Overall #1514
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #226
Overall #1514
Capital Expenditures Q/Q Growth Statistics
High Average Low
224.49 % 10.35 % -78.29 %
(Dec 31 2020)  


BSX's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2021 Boston Scientific Corporation reported fall in Capital Expenditures from the previous quarter by -52.83% to $ 75.00 millions, from $ 159.00 millions declared in the previous reporting period.

It's not important problem, as Capital Expenditures frequently tend to plunge in the I. Quarter.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Boston Scientific's Capital Expenditures growth quarter on quarter, overall rank is 1514.


Boston Scientific's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Capital Expenditures 12 Months Ending $ 351.00 $ 376.00 $ 403.00 $ 475.00 $ 498.00
Y / Y Capital Expenditures Growth (TTM) -29.52 % 159.31 % 520 % 2275 % 16500 %
Year on Year Capital Expenditures Growth Overall Ranking # 1027 # 91 # 29 # 4 # 1
Seqeuential Capital Expenditures Change (TTM) -6.65 % -6.7 % -15.16 % -4.62 % 243.45 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1031 # 1023 # 2253 # 639 # 24




Cumulative Capital Expenditures growth Comment
For the 12 months ended Mar 31 2021 Boston Scientific reported a drop in Capital Expenditures by -29.52% year on year, to $351 millions, compare to the 159.31% growth at Dec 31 2020.

In the Healthcare sector 168 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 91 to 1027.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1130.51 %
34.46 %
-99.05 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 42
Healthcare Sector # 169
Overall # 1027

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
16500 %
587.03 %
-98.88 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 178
S&P 500 # 1031
Cumulative Capital Expenditures growth Comment
For the 12 months ended Mar 31 2021 Boston Scientific reported a drop in Capital Expenditures by -29.52% year on year, to $351 millions, compare to the 159.31% growth at Dec 31 2020.

In the Healthcare sector 168 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 91 to 1027.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1130.51 %
34.46 %
-99.05 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 42
Healthcare Sector # 169
Overall # 1027

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
16500 %
587.03 %
-98.88 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 178
S&P 500 # 1031




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BSX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BSX's Competitors
Capital Expenditures Growth for Boston Scientific's Suppliers
Capital Expenditures Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2021
Baxter International Inc -0.58%$ -0.581 millions
Therapeuticsmd Inc -1.14%$ -1.135 millions
Tg Therapeutics inc -1.47%$ -1.471 millions
Teleflex Incorporated-2.07%$ -2.073 millions
Orthofix Medical Inc -3.30%$ -3.297 millions
Gilead Sciences Inc -3.51%$ -3.509 millions
Livanova Plc-4.39%$ -4.385 millions
Phibro Animal Health Corp-4.66%$ -4.660 millions
Deciphera Pharmaceuticals Inc -4.78%$ -4.783 millions
Amphastar Pharmaceuticals Inc -4.85%$ -4.846 millions
Bausch Health Companies Inc -5.56%$ -5.556 millions
Align Technology inc -5.76%$ -5.759 millions
Syneos Health Inc -5.87%$ -5.872 millions
Cytomx Therapeutics Inc -6.39%$ -6.387 millions
Davita Inc -6.47%$ -6.473 millions
Apollo Endosurgery inc -6.60%$ -6.604 millions
Bristol Myers Squibb Co-6.99%$ -6.989 millions
Resmed Inc -9.23%$ -9.234 millions
Bio rad Laboratories Inc -9.47%$ -9.467 millions
Laboratory Corporation Of America Holdings-10.51%$ -10.507 millions
X4 Pharmaceuticals Inc-10.63%$ -10.631 millions
Chemed Corporation-11.06%$ -11.057 millions
Biolase Inc -11.11%$ -11.111 millions
Siga Technologies Inc-11.46%$ -11.464 millions
Alnylam Pharmaceuticals Inc -12.43%$ -12.433 millions
Pra Health Sciences Inc -12.70%$ -12.703 millions
Intercept Pharmaceuticals inc -12.73%$ -12.731 millions
Shockwave Medical Inc -12.98%$ -12.975 millions
Nuvasive Inc-14.17%$ -14.167 millions
Biocryst Pharmaceuticals Inc-14.66%$ -14.655 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

U's Profile

Stock Price

U's Financials

Business Description

Fundamentals

Charts & Quotes

U's News

Suppliers

U's Competitors

Customers & Markets

Economic Indicators

U's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071